ALL in kids has a 91 percent cure rate or remission rate with the current treatment. annually there are 6000 cases in us, and there are 1600 adults. adults have a 40% survival rate and long term cure rate . With Juno's treatment it is increased to 59% so far in survival rate. However, there are some deaths with treatment. Also 80-90 % of adult ALL patients achieve remission. Juno's treatment has its place, but it is not a drastic change that leads to a cure rate of 91%. It is far from it. I think that Juno may come under pressure this week.
they know that csco will win big and anet will have to pay all the profits to them.
commodity prices will always reverse. It is when not if ever.
you do not know what you are talking about. Technically this stock is a sell for the shortterm, but the drug will be a blockbuster. Smart money including myself already sold above 100 when this thing failed to recover. Do you research and talk.
next week in Lisbon, Portugal. However, it is very hard to find their presentation on the abstracts. there are over 690s of them
aldr to double again from here
Fibonacci was not a billionaire. Neither are these MIT and Stanford professors. Those billionaires became billionaires from building up high tech companies in a short time. However, I doubt that these so call experts know what they are talking about. My calculation is August for a correction. But there will be cross currents with only certain sectors that are sensitive to interest rates.
to determine the cancer potential before it is approved. I think that this will be the only risk Blue is facing.
Blue needs to prove that it is safe. Momentum players are leaving Blue at a blistering pace now.
diabete empire is stronger than ever. I loaded up today with July calls.
more live births from augment.